Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population

PHASE1CompletedINTERVENTIONAL

Enrollment

588

Participants

Timeline

Start Date

November 6, 2015

Primary Completion Date

July 5, 2016

Study Completion Date

March 23, 2017

Conditions

Influenza A

Interventions

BIOLOGICAL

Influenza A (H7N9) virus vaccine

To prevent the infection of H7N9 virus.

All Listed Sponsors

lead

Hualan Biological Bacterin Co. Ltd.

INDUSTRY

NCT03196661 - Preliminary Study on Safety and Immunogenicity of Influenza A (H7N9) Vaccine in the Population | Biotech Hunter | Biotech Hunter